Literature DB >> 2127386

Studies on lipoamidase: characterization of the enzyme in human serum and breast milk.

B Backman-Gullers1, U Hannestad, L Nilsson, B Sörbo.   

Abstract

Lipoamidase activity was detected in human serum with both lipoyllysine (epsilon-N-(DL-lipoyl)-L-Lysine) and lipoylPABA (N-DL-lipoyl-p-aminobenzoate) as substrates, whereas lipoamidase in human milk used lipoylPABA, but not lipoyllysine as substrate. This suggested that lipoamidase activities in serum and milk are due to different enzymes. Studies with activators and inhibitors suggested that lipoamidase in serum using lipoylPABA as substrate may be a different enzyme from that using lipoyllysine as substrate. We suggest that these lipoamidases are named lipoyllysine hydrolase (LLH) and lipoylPABA hydrolase (LPH), respectively. Serum LLH was activated by thiol compounds and EDTA and strongly inhibited by sulfhydryl reagents whereas serum LPH was inhibited by sulfhydryl reagents but not activated by thiol compounds or EDTA. Milk LPH was unaffected by these reagents. We suggest that serum LLH and possibly serum LPH are cysteine proteases. LLH was adsorbed on Concanavalin A-Sepharose, indicating that LLH was a glycoprotein.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2127386     DOI: 10.1016/0009-8981(90)90057-y

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  4 in total

Review 1.  Lipoic acid metabolism in microbial pathogens.

Authors:  Maroya D Spalding; Sean T Prigge
Journal:  Microbiol Mol Biol Rev       Date:  2010-06       Impact factor: 11.056

2.  Co-purification of human serum lipoamidase and biotinidase: evidence that the two enzyme activities are due to the same enzyme protein.

Authors:  L Nilsson; B Kågedal
Journal:  Biochem J       Date:  1993-04-15       Impact factor: 3.857

3.  Biotinyl-methyl 4-(amidomethyl)benzoate is a competitive inhibitor of human biotinidase.

Authors:  Keyna A Kobza; Kittichai Chaiseeda; Gautam Sarath; James M Takacs; Janos Zempleni
Journal:  J Nutr Biochem       Date:  2008-05-13       Impact factor: 6.048

Review 4.  Lipoic acid metabolism of Plasmodium--a suitable drug target.

Authors:  Janet Storm; Sylke Müller
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.